Rajat Mehta's Insider Trades & SAST Disclosures

Rajat Mehta's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 4,601 Restricted Stock Units done . Disclosure was reported to the exchange on Sept. 4, 2026.

Share

Note

This is a custom search result for pattern Rajat Mehta.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations		04 Sep 2026	4,601	4,601	-		-	Restricted Stock Units
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations		04 Sep 2026	1,370	4,110	-		-	Restricted Stock Units
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Sep 2026	1,370	1,736 (0%)	0%		0	Bio-Rad A Common Stock
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.11 per share.	04 Sep 2026	504	1,232 (0%)	0%	386.1	194,599	Bio-Rad A Common Stock
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Sep 2026	456	599 (0%)	0%		0	Bio-Rad A Common Stock
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations		04 Sep 2026	456	1,371	-		-	Restricted Stock Units
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations	Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.11 per share.	04 Sep 2026	233	366 (0%)	0%	386.1	89,964	Bio-Rad A Common Stock
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations		05 Sep 2025	5,480	5,480	-		-	Restricted Stock Units
Bio-Rad Laboratories Inc (Class A)	Mr. Rajat Mehta	EVP, GBL Commercial Operations		05 Sep 2025	1,827	1,827	-		-	Restricted Stock Units

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades